The 17th Annual Diabetes Technology Meeting in Bethesda, MD earlier this month highlighted important technological and scientific advances for the management of diabetes. Senseonics Director of R&D, Dr. Andrew DeHennis was invited to participate in the panel discussion on Advances in Continuous Glucose Monitoring. As the only panel member from a company with an implantable, long-term wear CGM sensor, Dr. DeHennis was happy to contribute and speak on this topic. We thank the organizers and rest of panel for this important discussion.

By |2017-11-16T15:54:40+00:00November 20th, 2017|CGM, Science & Technology|0 Comments

About the Author:

Leave A Comment